Amphastar Pharmaceuticals
AMPH
AMPH
108 hedge funds and large institutions have $365M invested in Amphastar Pharmaceuticals in 2017 Q2 according to their latest regulatory filings, with 9 funds opening new positions, 34 increasing their positions, 48 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
44% less first-time investments, than exits
New positions opened: 9 | Existing positions closed: 16
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $16K
Holders
108
Holding in Top 10
–
Calls
–
Puts
$16K
Top Buyers
| 1 | +$20.3M | |
| 2 | +$4.83M | |
| 3 | +$4.2M | |
| 4 |
UBS AM
Chicago,
Illinois
|
+$3.81M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
+$3.13M |
Top Sellers
| 1 | -$4.71M | |
| 2 | -$4.7M | |
| 3 | -$4.4M | |
| 4 |
Acadian Asset Management
Boston,
Massachusetts
|
-$4.32M |
| 5 |
CCMH
Cornerstone Capital Management Holdings
New York
|
-$3M |